Gilead Sciences, Inc.

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$2.12B
Q ending 2026-03-31
Prior quarter
$1.94B
Q ending 2025-12-31
Change
+9.4% QoQ · +79.3% YoY
Positions
6
reported holdings

Largest positions

All 6 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Arcellx IncACLXShares$771.7M6.7M
Arcus Biosciences IncRCUSShares$678.8M31.4M
Galapagos NvLKFTShares$501.2M16.7M
Assembly Biosciences IncASMBShares$125.0M4.5M
Kyverna Therapeutics IncKYTXShares$35.6M4.1M
Xilio Therapeutics IncShares$5.5M650K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.